ImmunityBio has signed an exclusive US agreement with the Japanese BCG Laboratory to introduce the Tokyo strain BCG (Bacillus Calmette-Guérin vaccine).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang: No new legislation needed for AI safety, market forces are sufficient
Nvidia CEO Jensen Huang stated at the Salesforce Dreamforce conference that AI innovation and safety are not mutually exclusive. He believes that market mechanisms are sufficient to regulate the safety of AI products, and special legislation is not necessary. According to Huang, companies can fully ensure safety while advancing AI development, with the key being to control the pace of product releases until they are confident about market acceptance.
Market Chatter: NHTSA Presses Tesla On Cybercab Human Controls
The Clarity Act Stalls in the Senate, Cryptocurrency Bill Fails to Pass Key Vote
JPMorgan Expects Third-Quarter Gains in Investment Banking, Markets -- WSJ
Crypto prices
More
